Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Trillium Therapeutics Inc. T.TR

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  V.SSS| SCTPD| SCTPF

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.
Price: $20.17 Volume: 1,317
Change: $-0.08 % Change: -0.40%
Day High/Low: 20.17/19.89 52 Week High/Low: 37.27/7.02
Last Traded: November 27, 2015 06:25 Transaction Volume: 80
Open: 20.03 Previous Close: 20.25
Bid: 18.55 Ask: 20.20
Bid Size: 100 Ask Size: 100
Market Cap: 148.2m Shares Out: 7.3m
PE Ratio: N/A Dividend Yield: N/A


Technology that may save lives: Stem Cell Therapeutics

Stock has been fairly range-bound in terms of price since last May   March 16, 2009
0 stars

Latest Bullboard Posts